News
WASHINGTON (Reuters) -The United States has rejected amendments adopted in 2024 by members of the World Health Organization ...
Consumers who buy health insurance through the Affordable Care Act marketplace will likely face double-digit rate hikes next ...
1d
Pharmaceutical Technology on MSNCan rare disease research in the US thrive under the new administration?As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.
A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established ...
COVID-19 highlighted both the challenges of the US healthcare system and the huge change potential of the country’s pharmaceutical industry.
We spoke with Dr Kellan Baker of the Whitman-Walker institute to shed some light on the many changes taking place to various aspects of medical care for LGBTQ+ individuals.
WHO members adopt landmark pandemic agreement in US absence Accord aims to prevent repeat of disjointed response and international disarray that surrounded COVID-19 pandemic.
The justices ruled that a key preventive health task force has authority because it is appointed by the Health and Human ...
HHS touts universal flu, coronavirus vaccine initiative while casting doubt on future of seasonal Covid-19 shots ...
U.S. Health Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic, has been making sweeping changes to reshape regulation of vaccines, food and medicine.
The health of Black men, and by extension the health of entire communities, depends on it. However, recent legislative proposals threaten to undermine this potential.
Health-care policy in the US poses a challenge for investors, whereas there are areas of opportunity in the sector in Europe, according to John Maldonado, managing partner at Advent.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results